https://www.novumpr.nl/2019/10/22/takeda-verwerft-licentie-voor-eersteklas-coeliakie-therapie-van-cour-pharmaceuticals-na-positieve-fase-2a-proof-of-concept-studie/?utm_source=rss&utm_medium=rss&utm_campaign=takeda-verwerft-licentie-voor-eersteklas-coeliakie-therapie-van-cour-pharmaceuticals-na-positieve-fase-2a-proof-of-concept-studie NovumPR press releases Tue, 22 Oct 2019 08:55:21 +0000 hourly 1 https://wordpress.org/?v=6.8.3